
    
      Study population: Locally advanced unresectable pancreatic cancer patients

      Elegibility criteria:

        -  Written informed consent

        -  Age >18 < 75 years

        -  Histologically/cytologically confirmed locally advanced, unresectable pancreatic cancer

        -  At least one lesion measurable with CT or MRI scan

        -  Performance Status (ECOG) 0-1 at study entry

        -  Life expectancy of at least 3 months

        -  Adequate marrow, liver and renal function

        -  Effective contraception if the risk of conception exists (in the Informed Consent for
           the patients the descriptions of possible contraceptives is reported
    
  